These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3299813)

  • 1. Raynaud's phenomenon and systemic diseases.
    Kallenberg CG
    Vasa Suppl; 1987; 18():15-20. PubMed ID: 3299813
    [No Abstract]   [Full Text] [Related]  

  • 2. [Raynaud's phenomenon in systemic rheumatic diseases of the connective tissue].
    Maksimović B
    Reumatizam; 1983; 30(1-2):18-20. PubMed ID: 6867506
    [No Abstract]   [Full Text] [Related]  

  • 3. Electroencephalographic alterations in Raynaud's phenomenon.
    Delamonica EA; Velayos E; Shulman L
    Dis Nerv Syst; 1968 Nov; 29(11):748-53. PubMed ID: 5717290
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of biofeedback training in treatment of Raynaud's disease and phenomenon.
    Yocum DE; Hodes R; Sundstrom WR; Cleeland CS
    J Rheumatol; 1985 Feb; 12(1):90-3. PubMed ID: 3981523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Collagenoses and Raynaud's phenomenon].
    Guillaume JC; Touraine R
    Rev Prat; 1981 Dec; 31(55):4027-8 passim. PubMed ID: 7313482
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood rheology in Raynaud's disease].
    Larcan A; Schmidt C; Stoltz JF; Voisin P
    J Mal Vasc; 1984; 9(1):1-6. PubMed ID: 6707529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorrheology and neurovascular syndromes of the extremities].
    Sergio G; Artale F; Francisci A; Giunti P; Perego MA
    Ric Clin Lab; 1983; 13 Suppl 3():481-5. PubMed ID: 6673031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Raynaud's phenomenon and systemic diseases: immunological viewpoint].
    Lantin JP; Duc J
    Rev Med Suisse Romande; 1992 May; 112(5):401-4. PubMed ID: 1604100
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic (im)possibilities in Raynaud's phenomenon].
    Jager J
    Ned Tijdschr Geneeskd; 1996 May; 140(19):1044. PubMed ID: 8684503
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sympathectomy in treating Raynaud's disease in patients with collagenosis].
    Iudanova LS
    Sov Med; 1971; 34(8):138-40. PubMed ID: 5119640
    [No Abstract]   [Full Text] [Related]  

  • 11. [Physiopathology of Raynaud's phenomenon].
    Bollinger A
    Dtsch Med Wochenschr; 1982 Nov; 107(45):1699-701. PubMed ID: 7140547
    [No Abstract]   [Full Text] [Related]  

  • 12. Inefficacy of diltiazem in the treatment of Raynaud's phenomenon with associated connective tissue disease: a double blind placebo controlled study.
    da Costa J; Gomes JA; Espirito Santo J; Queirós M
    J Rheumatol; 1987 Aug; 14(4):858-9. PubMed ID: 3668998
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathogenesis of Raynaud's phenomenon.
    Herrick AL
    Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's phenomenon in systemic lupus erythematosus.
    Lavras Costallat LT; Valente Coimbra AM
    Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Raynaud's phenomena with trophic disorders].
    Vayssairat M
    J Mal Vasc; 1992; 17 Suppl B():127-31. PubMed ID: 1602249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagenosis and Raynaud phenomenon.
    Allen HB
    Arch Dermatol; 1973 Apr; 107(4):621-2. PubMed ID: 4697696
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of overlap syndrome with idiopathic, lactic acidosis and marked hypertension preceded by frequent Raynaud's phenomenon (author's transl)].
    Kobayashi H; Arikawa K; Tsugu T; Ichikawa Y; Homma M
    Nihon Naika Gakkai Zasshi; 1981 Apr; 70(4):586-90. PubMed ID: 7288242
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemorheology in patients with Raynaud's phenomenon--diagnosis and therapy with plasmapheresis].
    Sakriss U; Toussaint C; Turowski A; Schmidt H; Nieter B
    Vasa Suppl; 1991; 32():347-9. PubMed ID: 1771530
    [No Abstract]   [Full Text] [Related]  

  • 19. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood viscosity, Raynaud's phenomenon and the effect of fibrinolytic enhancement.
    Ayres ML; Jarrett PE; Browse NL
    Br J Surg; 1981 Jan; 68(1):51-4. PubMed ID: 7459607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.